Related Experiment Video
Updated: Oct 11, 2025
07:11
Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography
Published on: October 28, 2020
3.0K
Association Between Left Ventricular Global Function Index and Outcomes in Patients With Dilated Cardiomyopathy
Tong Liu1,2,3, Zhen Zhou4, Kairui Bo4
1Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Frontiers in Cardiovascular Medicine
|December 6, 2021
Summary
Left ventricular global function index (LVGFI) measured by cardiac magnetic resonance (CMR) predicts better outcomes in dilated cardiomyopathy (DCM) patients. Higher LVGFI is linked to fewer major adverse cardiac events (MACEs), indicating its prognostic value in heart failure.
Area of Science:
- Cardiology
- Medical Imaging
- Heart Failure Research
Background:
- Left ventricular global function index (LVGFI) assessed by cardiac magnetic resonance (CMR) shows promise for predicting clinical outcomes.
- The prognostic role of LVGFI in heart failure (HF) patients with dilated cardiomyopathy (DCM) remains uncertain.
Purpose of the Study:
- To investigate the association between LVGFI and clinical outcomes in patients with DCM.
- To determine if LVGFI can predict major adverse cardiac events (MACEs) in this patient population.
Main Methods:
- A prospective cohort study involving 334 consecutive DCM patients who underwent CMR between January 2015 and April 2020.
- LVGFI was the primary exposure variable, with outcomes assessed using multivariable models adjusted for confounders.
- The composite endpoint included death or heart transplantation over a median follow-up of 565 days.
Main Results:
- Patients with LVGFI below 15.73% had a significantly higher incidence of the composite endpoint (P = 0.0021).
- Each 1 SD increase in LVGFI was associated with a 38% decrease in MACEs (HR 0.62), and this association persisted after adjustment (46% decrease, HR 0.54).
- Subgroup analyses confirmed the consistency of these findings.
Conclusions:
- Increased CMR-assessed LVGFI is associated with a reduced long-term risk of MACEs in patients with DCM.
- LVGFI serves as a valuable prognostic marker in DCM, independent of traditional risk factors.
- These findings support the utility of LVGFI in risk stratification for DCM patients.
Related Concept Videos
01:30Cardiomyopathy II: Dilated Cardiomyopathy
60
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
60
01:29Cardiomyopathy V: Interprofessional Care
61
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
61
01:29Heart Failure II: Pathophysiology
96
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
96
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
86
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
86
01:30Heart Failure IV: Classification and Diagnostic Evaluation
73
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
73
01:17Pathophysiology of Heart Failure
2.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.0K